Research & KnowledgeEvent: September 3, 2026
AstraZeneca is investing in science focused on factors contributing to uncontrolled hypertension and interconnected disease.
Published
Signal category
Research & Knowledge
Quote
“It's encouraging to see AstraZeneca continuing to invest in science focused on the factors contributing to uncontrolled hypertension and interconnected disease.”
— Sophie Fraissignes|AstraZeneca team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- Cambridge, GB
- Company size
- 82,045 employees
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio